Latest Breaking News On - Checkmate pharmaceuticals - Page 4 : comparemela.com

Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer

- Veronica Hersberger appointed as Senior Vice President, Medical Affairs- Miranda Neville promoted to Senior Vice President, Project Management and will continue to lead the obe-cel program LONDON,.

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma

Cancer Vaccines Clinical Trial Pipeline Analysis

The prevalence of cancer has been rising over the past few years, which prompts the growing demand for treatment options. The introduction of cancer.

Form 10-Q XOMA Corp For: Mar 31

Pembrolizumab Monotherapy Effective for Rare Melanoma

Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.